Catibig, Baby Girl .
HRN: 24-44-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/21/2024
01/28/2024
IV
20mg
Q36
PRETERM; PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes